• Home
  • The Ranking of Fraudulent Financial Reporting By Using Data Envelopment Analysis: Case of Pharmaceutical Listed Companies

Share To

Article Url


Manuscript ID : AMFA-1902-1193 (R1) Visit : 260 Page: 69 - 80

10.22034/amfa.2019.1863571.1193

Article Type: Original Research

Related articles